Notice bibliographique
- Notice
Type(s) de contenu et mode(s) de consultation : Texte noté : électronique
Titre(s) : TNF-alpha inhibitors [Texte électronique] / edited by J.M. Weinberg and R. Buchholz
Publication : Basel ; Boston : Birkhäuser Verlag, cop. 2006
Description matérielle : 1 ressource dématérialisée
Collection : Milestones in drug therapy
Note(s) : Includes bibliographical references and index
"This volume provides a comprehensive overview of the development, pharmacology, efficacy,
and safety of the currently available TNF alpha inhibitors - etanercept, infliximab,
and adalimumab. The most recent preclinical and clinical data is presented on this
topic, which should be of interest to the preclinical researcher, the clinician, and
the patient who wants to learn more about these therapies."--Jacket
Autre(s) auteur(s) : Weinberg, Jeffrey M. (1961-....). Fonction indéterminée
Buchholz, Robin. Fonction indéterminée
Sujet(s) : TNF (cytokines) -- Inhibiteurs
Anti-inflammatoires
Indice(s) Dewey :
616.079 (23e éd.) = Immunité (médecine)
Identifiants, prix et caractéristiques : ISBN 9783764374389
Identifiant de la notice : ark:/12148/cb447146769
Notice n° :
FRBNF44714676
(notice reprise d'un réservoir extérieur)
Table des matières : Introduction to TNF/pathophysiology of TNF /Patricia Malerich and Dirk M. Elston ;
History of development of TNF inhibitors /Seth R. Stevens and Ting H. Chang ; Pharmacology
of TNF inhibitors /Rahul Shukla and Ronald B. Vender ; Etanercept in rheumatology
/Jeffrey D. Greenberg and Mitsumasa Kishimoto ; Etanercept in dermatology and off-label
use /Noah Gratch and Andrew F. Alexis ; Infliximab in rheumatology /Mihaela B. Taylor
and Dahlia T. Lainer ; Infliximab in dermatology, gastroenterology, and off-label
use /Noah Scheinfeld ; Adalimumab in rheumatology /Harry D. Fischer ; Adalimumab in
dermatology /Jennifer Clay Cather and Melodie Young ; A review of the safety of the
tumor necrosis inhibitors infliximab, etanercept, and adalimumab /Jeffrey M. Weinberg
